Approvals/CIMA-AEMPS/NAPROXENO/ESOMEPRAZOL SANDOZ 500 MG/20 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG

Approved

STANDARD

NAPROXENO/ESOMEPRAZOL SANDOZ 500 MG/20 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG

Sandoz Farmaceutica S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 79a05c88afdb3f69
Drug Cima Aemps Name: NAPROXENO/ESOMEPRAZOL SANDOZ 500 MG/20 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG
Register Number: 89990
Holder Company Name: Sandoz Farmaceutica S.A.
Marketing Company Name: Sandoz Farmaceutica S.A.
Authorization Date: 2024-12-04
Dosage Form: COMPRIMIDO DE LIBERACIÓN MODIFICADA
Dose: 500 mg/20 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Sandoz Farmaceutica S.A.

NAPROXENO

500 mg

ESOMEPRAZOLE MAGNESIO TRIHIDRATO

22,3 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 4, 2024

Approval ID

79a05c88afdb3f69

Type

Standard